ArticleEye (London, England)2011
Incorporating life expectancy in glaucoma care.
Article in Eye (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Influence of glaucoma surgery on visual function: a clinical cohort study and meta-analysis.Acta ophthalmologica · 2019Pooled it
- Sustained Release Therapies with the Prostaglandin Analogues Intracameral Implants.Ophthalmology and therapy · 2024Article
- Progression to blindness in 20 years among patients with glaucomatous visual field loss in a tertiary hospital in the Philippines.BMJ open ophthalmology · 2020Article
- Detection and measurement of clinically meaningful visual field progression in clinical trials for glaucoma.Progress in retinal and eye research · 2017Review
- What rates of glaucoma progression are clinically significant?Expert review of ophthalmology · 2016Article
- Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data.Eye (London, England) · 2015Article
- Long Term Results of Visual Field Progression Analysis in Open Angle Glaucoma Patients Under Treatment.The open ophthalmology journal · 2015Article
- Five-year forecasts of the Visual Field Index (VFI) with binocular and monocular visual fields.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo calculate for which combinations of age and perimetric disease stage glaucoma patients are unlikely to become visually impaired during their lifetime.
methodsWe used residual life expectancy data (life expectancy adjusted for the age already reached) as provided by Statistics Netherlands and rates of progression as derived from published studies. We calculated the baseline mean deviation (MD) for which an individual would reach a MD of -20 dB at the end of life as a function of age and rate of progression. For situations in which the individual rate of progression is unknown, we used the 90th percentiles of rate of progression and residual life expectancy. For situations in which the individual rate of progression is known, we used the 95th percentile of the residual life expectancy.
resultsAn easily applicable graphical tool was developed that enables an accurate estimate of the probability of becoming visually impaired during lifetime, given age, current glaucomatous damage, and--if available--the individual rate of progression.
conclusionsThis novel tool enables the clinician to incorporate life expectancy in glaucoma care in a well-founded manner and may serve as a starting point for personalized decision making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.